bopindolol has been researched along with celiprolol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lefflerová, K; Widimský, J | 1 |
| Doggrell, SA; Henderson, CJ | 1 |
| Hayakawa, H; Hirata, Y; Kakoki, M; Kikuchi, K; Nagano, T; Nagata, D; Nishimatsu, H; Omata, M; Suzuki, E; Suzuki, Y | 1 |
| Aly, F; Belal, F; El-Awady, M; Hefnawy, M; Sharaf El-Din, M | 1 |
1 review(s) available for bopindolol and celiprolol
| Article | Year |
|---|---|
Betablockers in the treatment of hypertension (with special emphasis on betablockers with ISA). A review.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Celiprolol; Humans; Hypertension; Labetalol; Middle Aged; Pindolol; Propanolamines | 1988 |
3 other study(ies) available for bopindolol and celiprolol
| Article | Year |
|---|---|
The offset of beta-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Celiprolol; Heart Ventricles; Isoproterenol; Male; Myocardial Contraction; Pindolol; Propranolol; Rats; Rats, Wistar | 1998 |
Effects of vasodilatory beta-adrenoceptor antagonists on endothelium-derived nitric oxide release in rat kidney.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Benzopyrans; Celiprolol; Desoxycorticosterone; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethanolamines; Hypertension; In Vitro Techniques; Kidney; Male; Metergoline; Muscle, Smooth, Vascular; Nebivolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Pindolol; Piperazines; Piperidines; Platelet Aggregation Inhibitors; Quinazolines; Rats; Rats, Wistar; Renal Circulation; Serotonin Antagonists; Vasoconstriction; Vasodilator Agents | 1999 |
Fluorometric determination of bopindolol and celiprolol in pharmaceutical preparations and biological fluids.
Topics: Celiprolol; Drug Compounding; Fluorometry; Humans; Limit of Detection; Linear Models; Pindolol; Solvents | 2012 |